Quoin Pharmaceuticals, Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$8,686,573 over the previous period. Total operating expenses were $9,378,504.

Profit Margin

Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX): Profit margin
2015 0 -2.61M
2016 -280K 15.31M -5470.36%
2017 0 10.17M
2018 -280K 15.31M -5470.36%
2019 0 -1.56M
2020 0 -1.76M
2021 0 -8.51M
2022 0 -9.27M
2023 0 -8.68M

QNRX Income Statement (2015 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
00000-280K0-280K0
Cost of revenue
103.43K103.63K104.11K104.77K227.05K0104.22K018.27K
Gross profit
-103.43K-103.63K-104.11K-104.77K-227.05K-280K-104.22K-280K-18.27K
Operating exp.
Research and development
3.19M2.67M1.56M244.15K45.65K8.25M5.89M8.25M1.51M
Selling and marketing
000000000
Total operating expenses
9.37M9.25M6.06M1.67M1.56M16.22M10.09M16.22M2.58M
Operating income
-9.37M-8.84M-20.37M-2.04M-1.56M15.31M10.17M15.31M-2.59M
Other income (expenses), net
714.31K-532.80K-1.09M-425.35K1.55M0-1.06M0-19.30K
Income before tax
-8.66M-9.38M-21.46M-2.09M-1.56M15.31M10.17M15.31M-2.61M
Income tax expense
22.38K-104.04K-12.94M-331.31K1.55M0-1.16M0-1
Net income
-8.68M-9.27M-8.51M-1.76M-1.56M15.31M10.17M15.31M-2.61M
Earnings per share
Basic EPS
-9.64-22.97-322.49-88.1-440.290.005.45K0.00-2.10K
Diluted EPS
-9.64-22.97-322.49-88.1-440.290.005.45K0.00-2.10K
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData source